share_log

Piper Sandler Maintains Overweight on Gritstone Bio, Raises Price Target to $7

Benzinga ·  Sep 28, 2023 19:53

Piper Sandler analyst Edward Tenthoff maintains Gritstone Bio (NASDAQ:GRTS) with a Overweight and raises the price target from $6 to $7.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment